New Order Aims to Reduce Prescription Drug Prices

Most voters believe prescription drugs expensive mainly due to Big Pharma greed, poll finds

According to the survey results, 31% of voters think that forcing pharmaceutical companies to lower prices will "reduce the number of new and better drugs that those companies are able to create" and 45% said it will not.

Congress Finally Takes Action To Codify Trump's Moves Into Law - The American Tribune.com

In a stunning moment from the floor of the House, Democrat Rep. Ro Khanna (CA) crossed party lines to endorse Trump’s new executive order slashing the prices of prescription drugs by up to 80%. This is a potentially monumental event for the President, as defections could weaken the already faltering Democratic Party. For context, while most Democrats have fallen into deep Trump Derangement Syndrome (TDS), some moderates, such as Khanna and Senat…

New order aims to reduce prescription drug prices

(CNN, KYMA/KECY) – President Donald Trump has signed an executive order that aims to cut prescription drug prices. A White House official says that this action makes it a promise to crack down on other countries' unreasonable practices that suppress drug prices. The administration's executive order would apply to a wide range of drugs and prices on the commercial market that would also include Medicare and Medicaid. The Department of Health and …

Trump sets 30-day deadline for drugmakers to lower prescription drug costs

WASHINGTON, D.C. — President Donald Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits over what the government will pay. The order calls on the health department, led by Robert F. Kennedy

Trump Administration Doubles Down on Big Pharma Pressure - Wall Street Pit

The Trump administration is pushing to lower U.S. drug prices to match those in other developed nations through the Most Favored Nation executive order, while also proposing a 20% tariff on medicines made outside the U.S. to encourage domestic manufacturing. Major pharmaceutical companies, including Roche (RHHBY), Johnson & Johnson (JNJ),…

Executive order sets drug price targets for most-favored-nations - The Cancer Letter

On May 12, President Trump signed an executive order directing the administration to communicate most-favored-nation drug price targets to pharmaceutical manufacturers for sales in the United States. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/register t…